Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
TLR9 Immunotherapy for Peritoneal Carcinomatosis (TIPC) - Phase 1 Study of the Safety and Efficacy of ACM-CpG Intraperitoneal Injections for Treatment in Patients With Colorectal or Appendiceal Adenocarcinoma Peritoneal Metastases or Malignant Ascites
The goal of this clinical trial is to determine the safety and efficacy of of ACM-CpG for inoperable peritoneal metastases or malignant ascites. The main quest…
Malignant AscitesColorectal AdenocarcinomaPeritoneal (Metastatic) Cancer+1 more
Estimated
~$10 – $6,250
Brown UniversityNCT07658196
Phase 1
Phase I Intra-patient Dose Escalation Study of the IL-6 Receptor Antagonist Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Pleural Effusion or Peritoneal Ascites Due to Metastatic Cancer
The purpose of this study to find out if tocilizumab can be safely infused into chest or abdominal cavities of patients with malignancy ascites (MA) or maligna…
Malignant Pleural EffusionMalignant Ascites
Estimated
~$10 – $7,500
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)NCT06016179
Observational
A Pilot Study of At-Home Paracentesis for Women With Cancer-Related Malignant Ascites: A Decentralized Interventional Treatment Trial (Paracentesis)
The goal of this study is to evaluate the change in symptoms for women with cancer-related malignant ascites who complete an at-home paracentesis procedure.
Malignant Ascites
Estimated
~$10 – $6,250
University of UtahNCT07490626